COVINGTON, Ky.--(BUSINESS WIRE)--Omnicare, Inc. (NYSE:OCR) today issued the following statement correcting the misstatements made by Gregory Weishar, Chief Executive Officer of PharMerica Corporation (NYSE: PMC), in a letter to Omnicare dated November 14, 2011:
Since Omnicare launched its tender offer to purchase all of the outstanding shares of PharMerica common stock for $15.00 per share in cash, our goals and intentions have been clear. We want to negotiate a mutually acceptable transaction and are willing to work with PharMerica to allay potential concerns regarding the process to reach an agreement.
Since Omnicare launched its tender offer to purchase all of the outstanding shares of PharMerica common stock for $15.00 per share in cash, our goals and intentions have been clear. We want to negotiate a mutually acceptable transaction and are willing to work with PharMerica to allay potential concerns regarding the process to reach an agreement.